<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./10_1101_2020_03_22_002386v3/results/search/funders/results.xml">
  <result pre="BridGene Biosciences, Denali Therapeutics, Dice Molecules, eFFECTOR Therapeutics, Erasca, Genentech/Roche," exact="Janssen Pharmaceuticals," post="Kumquat Biosciences, Kura Oncology, Merck, Mitokinin, Petra Pharma, Qulab"/>
  <result pre="the manuscript. This research was funded by grants from the" exact="National Institutes of Health" post="(P50AI150476, U19AI135990, U19AI135972, R01AI143292, R01AI120694, P01A1063302, and R01AI122747 to"/>
  <result pre="K08HL124068 to J.S.C.; 1F32CA236347-01 to J.E.M.); funding from F. Hoffmann-La" exact="Roche" post="and Vir Biotechnology and gifts from The Ron Conway"/>
  <result pre="The Ron Conway Family. K.M.S is an investigator of the" exact="Howard Hughes Medical Institute." post="Footnotes Added DNA sequences, responded to comments, authorship update"/>
  <result pre="antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK." exact="EMBO" post="J. 26, 3180– 3190 ( 2007). OpenUrl Abstract /"/>
  <result pre="FREE Full Text 83. ↵ Organization, W. H. &amp;amp;; Others." exact="World Health Organization" post="model list of essential medicines: 21st list 2019. https://apps.who.int/iris/handle/10665/325771"/>
  <result pre="novel class of HDAC inhibitors inducing differentiation of transformed cells." exact="EMBO" post="J. 20, 6969– 6978 ( 2001). OpenUrl Abstract /"/>
  <result pre="deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2." exact="EMBO" post="J. 22, 3411– 3420 ( 2003). OpenUrl Abstract /"/>
 </snippets>
</snippetsTree>
